Skip to main content

Advertisement

SpringerLink
Log in

The efficacy of ustekinumab on the articular and dermatologic manifestations of psoriatic arthritis

  • Clinical Trials Report
  • Published:
Current Rheumatology Reports Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Gladman DD: Current concepts in psoriatic arthritis. Curr Opin Rheumatol 2002, 14:361–370.

    Article  PubMed  Google Scholar 

  2. McHugh NJ, Balachrishnan C, Jones SM: Progression of peripheral joint disease in psoriatic arthritis: a 5-year prospective study. Rheumatology (Oxford) 2003, 42:778–783.

    Article  CAS  Google Scholar 

  3. Mease PJ, Kivitz AJ, Burch FX, et al.: Etanercept treatment of psoriatic arthritis: safety, efficacy and effect on disease progression. Arthritis Rheum 2004, 50:2264–2272.

    Article  PubMed  CAS  Google Scholar 

  4. Antoni C, Krueger GG, de Vlam K, et al.: Infliximab improves signs and symptoms of psoriatic arthritis: results of the IMPACT 2 trial. Ann Rheum Dis 2005, 64:1150–1157.

    Article  PubMed  CAS  Google Scholar 

  5. Mease PJ, Gladman DD, Ritchlin CT, et al.: Adalimumab for the treatment of patients with moderately to severely active psoriatic arthritis: results of a double-blind, randomized, placebo-controlled trial. Arthritis Rheum 2005, 52:3279–3289.

    Article  PubMed  CAS  Google Scholar 

  6. Krueger GC, Langley RG, Leonardi CL, et al.: A human interleukin 12/23 monoclonal antibody for the treatment of psoriasis. N Engl J Med 2007, 356:580–592.

    Article  PubMed  CAS  Google Scholar 

  7. Leonardi CL, Kimball AB, Papp KA, et al.: Efficacy and safety of ustekimumab, a human interleukin 12/23 monoclonal antibody in patients with psoriasis: 76-week results from a randomized, double-blind, placebo-controlled trial (PHOENIX 1). Lancet 2008, 371:1665–1674.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Rheumatology, Allergy and Immunology, UCSD Thornton Hospital, University of California, San Diego, USA

    Arthur Kavanaugh

  2. 9500 Gilman Drive, Room A-112, La Jolla, CA, 92093, USA

    Arthur Kavanaugh

Authors
  1. Arthur Kavanaugh
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Arthur Kavanaugh.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kavanaugh, A. The efficacy of ustekinumab on the articular and dermatologic manifestations of psoriatic arthritis. Curr Rheumatol Rep 11, 233–234 (2009). https://doi.org/10.1007/s11926-009-0043-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11926-009-0043-z

Keywords

Search

Navigation